Movement Disorder News and Research

Latest Movement Disorder News and Research

New noninvasive treatment option improves quality of life in patients with essential tremor

Treatment with MRI-guided focused ultrasound significantly improves tremors and quality of life in patients with essential tremor (ET), the most common movement disorder, according to a study published in the August 25 issue of the New England Journal of Medicine.

25 Aug 2016

FDA approves scalpel-free brain surgery to treat essential tremor

The Food and Drug Administration has approved the first focused ultrasound device to treat essential tremor, the most common movement disorder, in patients who do not respond to medication.

21 Jul 2016

Researchers identify potential biomarker for Parkinson's disease in biobanked urine samples

For more than five years, urine and cerebral-spinal fluid samples from patients with Parkinson's disease have been locked in freezers in the NINDS National Repository, stored with the expectation they might someday help unravel the still-hidden course of this slow-acting neurodegenerative disease.

6 Jul 2016

New study reveals increasing trend in Parkinson's disease over 30 years

The incidence of Parkinson's disease and parkinsonism increased significantly in 30 years from 1976 to 2005, Mayo Clinic researchers reported today in a study in JAMA Neurology.

21 Jun 2016

Decision-making dysfunction may be key contributor to movement disorder symptoms in Parkinson’s patients

UCLA researchers have discovered that people with Parkinson's disease have a form of impaired decision-making that may be a major contributor to the movement problems that characterize the disease.

17 Jun 2016

RIKEN joins with Grace Science Foundation to gain better understanding of NGLY1 deficiency

RIKEN has entered into a collaboration with the Grace Science Foundation to conduct research on NGLY1 deficiency, a rare genetic disorder that was discovered in 2012 by American doctors.

15 Jun 2016

Innovative advances in medical paediatric orthotics shared at Primary Care and Public Health 2016

Innovative, clinician-led advances in orthotic techniques have the capacity to dramatically improve short term progress and long term outcomes for selective dorsal rhizotomy and scoliosis patients as well as patients with neurological disorders affecting movement.

13 Jun 2016

Northwestern Medicine scientists link TMEM230 gene mutations to Parkinson's disease development

Northwestern Medicine scientists have discovered a new cause of Parkinson's disease -- mutations in a gene called TMEM230. This appears to be the third gene definitively linked to confirmed cases of the common movement disorder.

7 Jun 2016

Experts discuss new insights into early stages of Parkinson’s disease at EAN Congress

Early diagnosis and starting treatment as early as possible are decisive factors in achieving improved quality of life for Parkinson's sufferers. Experts are discussing a wide range of new insights into the early stages of the disease at the Congress of the European Academy of Neurology in Copenhagen.

31 May 2016

Studies show how speaking French could significantly reduce symptoms of Benign Essential Blepharospasm

A fascinating new study published in the latest edition of Movements Disorders (Vol.00 No.00, 2016) presents two patient case studies that demonstrate how speaking French as a second language can significantly reduce the symptoms of a life-limiting eye condition, Benign Essential Blepharospasm (BEB).

17 May 2016

Oral administration of Jakinibs reduces Parkinson's disease pathogenesis in rat model

University of Alabama at Birmingham researchers report the first documentation that suppressing a key cell-signaling pathway in a rat model of Parkinson's disease reduces pathogenesis. Oral administration of AZD1480 — one of the JAK/STAT pathway inhibitors generally known as Jakinibs — lessened the destructive inflammation and nerve cell degradation in the area of the brain affected by Parkinson's.

4 May 2016

Dopamine neuron transplants controlled by designer drug may fight Parkinson's disease in mice

A University of Wisconsin-Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell. The cells in question are neurons and make the neurotransmitter dopamine, whose deficiency is the culprit in the widespread movement disorder Parkinson's disease.

29 Apr 2016

AAN’s updated guideline on botulinum toxin use covers four neurologic disorders

The American Academy of Neurology has updated its 2008 guidelines on the use of botulinum toxin for spasticity, cervical dystonia, blepharospasm and migraine headache, based on recent research.

19 Apr 2016

Researchers identify new mutation responsible for spinocerebellar ataxia

Using the genetic information of two different families with three generations of disease, researchers have identified a new mutation responsible for a degenerative and ultimately fatal movement disorder. Through induced pluripotent stem cell techniques, researchers also grew neurons from one patient in the laboratory to be used in future experiments.

15 Mar 2016

Researchers reveal link between intensive instrument playing and movement disorders

A musician takes up his/her violin and starts to play, but rather than gripping the strings, the fingers seize up—and this happens every time he/she takes up the instrument. Such a movement disorder—the so-called focal dystonia— is a dramatic disease for those affected, which has thus far barely been studied.

25 Jan 2016

Anticholinergic medications do not affect cognitive performance in PD patients

Recent evidence has shown a greater risk of dementia, in particular Alzheimer's disease (AD), in individuals using anticholinergic medications regularly. These drugs are widely used by older adults to treat bladder dysfunction, mood, and pain, and many of them are available without prescription.

5 Jan 2016

Ketogenic diet may be effective in treating schizophrenia

Research by James Cook University scientists has found a diet favoured by body-builders may be effective in treating schizophrenia.

17 Dec 2015

Diseases that cause skin-related problems can also trigger serious neurological conditions

Diseases such as lupus that cause rashes and other skin problems also can trigger migraine headaches, strokes and other serious neurological conditions, according to an article by Loyola University Medical Center physicians.

16 Dec 2015

UC San Diego researchers awarded MJFF grant to identify biomarkers for Parkinson's disease

Parkinson's disease is difficult to diagnose, particularly in its early stages. Now, researchers at University of California, San Diego School of Medicine - aided by a $375,000 grant from The Michael J. Fox Foundation for Parkinson's Research - hope to improve the prospects of early diagnosis by identifying a biological signpost in the blood.

9 Dec 2015

Impax's NUMIENT granted EC marketing authorization for symptomatic treatment of adult patients with Parkinson's disease

Impax Laboratories, Inc. today announced that the European Commission has granted marketing authorization for NUMIENT (Levodopa and Carbidopa), a modified-release oral capsule formulation for the symptomatic treatment of adult patients with Parkinson's disease.

25 Nov 2015

Movement Disorder News and Research

Latest Movement Disorder News and Research

New noninvasive treatment option improves quality of life in patients with essential tremor

FDA approves scalpel-free brain surgery to treat essential tremor

Researchers identify potential biomarker for Parkinson's disease in biobanked urine samples

New study reveals increasing trend in Parkinson's disease over 30 years

Decision-making dysfunction may be key contributor to movement disorder symptoms in Parkinson’s patients

RIKEN joins with Grace Science Foundation to gain better understanding of NGLY1 deficiency

Innovative advances in medical paediatric orthotics shared at Primary Care and Public Health 2016

Northwestern Medicine scientists link TMEM230 gene mutations to Parkinson's disease development

Experts discuss new insights into early stages of Parkinson’s disease at EAN Congress

Studies show how speaking French could significantly reduce symptoms of Benign Essential Blepharospasm

Oral administration of Jakinibs reduces Parkinson's disease pathogenesis in rat model

Dopamine neuron transplants controlled by designer drug may fight Parkinson's disease in mice

AAN’s updated guideline on botulinum toxin use covers four neurologic disorders

Researchers identify new mutation responsible for spinocerebellar ataxia

Researchers reveal link between intensive instrument playing and movement disorders

Anticholinergic medications do not affect cognitive performance in PD patients

Ketogenic diet may be effective in treating schizophrenia

Diseases that cause skin-related problems can also trigger serious neurological conditions

UC San Diego researchers awarded MJFF grant to identify biomarkers for Parkinson's disease

Impax's NUMIENT granted EC marketing authorization for symptomatic treatment of adult patients with Parkinson's disease

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Movement Disorder News and Research

Latest Movement Disorder News and Research

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in